|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Filariasis | |||||
| Helminthiasis | |||||
| Loiasis | |||||
| Mansonelliasis | |||||
| Onchocerciasis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Infection | |||||
| 3 | More general conditions related to this trial | ||||
| Nematode Infections | |||||
| Parasitic Diseases | |||||
| Secernentea Infections | |||||
| Skin Diseases | |||||
| Skin Diseases, Infectious | |||||
| Skin Diseases, Parasitic | |||||
| Spirurida Infections | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||